Express Healthcare
Home  »  News  »  Neuberg Diagnostics appoints VB Gopal Krishnan as Group Chief Financial Officer

Neuberg Diagnostics appoints VB Gopal Krishnan as Group Chief Financial Officer

0 407
Read Article

Krishnan has over two decades of experience in areas of treasury, project finance, system implementation, corporate affairs, accounting, debt restructuring, business finance, costing and taxation

Neuberg Diagnostics recently announced the appointment of VB Gopal Krishnan as the Group Chief Financial Officer.

Krishnan, who has over two decades of experience in the areas of treasury, project finance, system implementation, corporate affairs and accounting, debt restructuring, business finance, costing and taxation will be heading Neuberg’s Financial, legal and IT functions.

“We are delighted to have Gopal onboard at Neuberg. He is a seasoned professional with a proven track record in improving operations, effecting business growth and maximising profits through innovative financial strategies. In his new role, he will be at the helm of Neuberg’s finances, organisational growth and expansion plans. I am confident that he will bring in a lot of experience and value to Neuberg and our leadership team. We look forward to an exciting journey with him and wish him all the success at Neuberg,” said Dr GSK Velu, Chairman & Managing Director, Neuberg Diagnostics. 

Krishnan is a commerce graduate, an Associate Member of Institute of Chartered Accountants of India and Diploma in International Financial Reporting set and Accredited by Association of Chartered Certified Accountants UK. Prior to joining Neuberg, he served as the CFO at Rajshree Sugars and Chemicals. In his earlier assignments he held responsible positions at Uttam Sucrotech international, EID Parry (India) and Paharpur Cooling Towers.

Commenting on his appointment, Krishnan said,  “Neuberg has tremendous potential in the diagnostics space today. I am honoured and overwhelmed to be part of this dynamic organisation promoted by none other than Dr GSK Velu, a name that needs no introduction in the healthcare industry. I look forward to closely working with the entire team in realising Neuberg Diagnostics’ vision and mission. My primary focus will be to grow Neuberg to a strong position in the country and to model the desired changes for further growth and expansion.”

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image